25Nov/13

More pediatric kidney patients are being treated with minimally invasive … – Medical Xpress

More pediatric kidney patients are being treated with minimally invasive
Medical Xpress
Those conclusions were reached in a unique study by researchers at Henry Ford Hospital who set out to fill a knowledge gap about the use of nephrectomy – the surgical removal of a diseased kidney – in the U.S. pediatric population. Published online in

and more »

25Nov/13

Sonia Gandhi congratulates India's first liver transplant recipient – Parda Phash


Parda Phash

Sonia Gandhi congratulates India’s first liver transplant recipient
Parda Phash
enjoys meals, plays football and wants to become a doctor to save lives. Sanjay’s success helped establish liver transplantation in India,” said Anupam Sibal, senior paediatric gastroenterologist in the hospital. Babulal Nagar’s judicial custody
Sonia Gandhi felicitates liver transplant recipientBusiness Standard

all 3 news articles »

25Nov/13

Boston Scientific Gets FDA Approval For Promus Premier Everolimus-EPCCS … – RTT News

Boston Scientific Gets FDA Approval For Promus Premier Everolimus-EPCCS
RTT News
Boston Scientific Corp. (BSX: Quote) said Monday that it has received U.S. Food and Drug Administration or FDA approval for the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System, the company’s next-generation durable 
Boston Scientific Receives FDA Approval For Promus Premier(TM) Everolimus Wall Street Journal
Boston Scientific Receives FDA Approval For Promus Premier Everolimus Benzinga
FDA approves next-generation EESHealio
Forbes –MedCity News –Worcester Business Journal
all 10 news articles »
25Nov/13

Boston Scientific Corporation : Boston Scientific Receives FDA Approval For … – 4-traders (press release)

Boston Scientific Corporation : Boston Scientific Receives FDA Approval For
4-traders (press release)
25, 2013/PRNewswire/ — Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the Promus PREMIER™ Everolimus-Eluting 

25Nov/13

Boston Scientific Gets FDA Approval For Promus Premier Everolimus-EPCCS … – NASDAQ

Boston Scientific Gets FDA Approval For Promus Premier Everolimus-EPCCS
NASDAQ
(RTTNews.com) – Boston Scientific Corp. ( BSX ) said Monday that it has received U.S. Food and Drug Administration or FDA approval for the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System, the company’s next-generation 
Boston Scientific Receives FDA Approval For Promus Premier(TM) Everolimus Wall Street Journal
FDA approves next-generation EESHealio
BSX scores FDA device approval for drug-eluting stent for coronary artery MedCity News
Worcester Business Journal
all 10 news articles »